Basis of Presentation - Additional Information (Details) $ in Thousands		9 Months Ended
	Jul. 07, 2023 shares	Sep. 30, 2023 USD ($) shares	Sep. 30, 2022 USD ($)	Jul. 06, 2023 shares	Dec. 31, 2022 USD ($) shares
Inventory [Line Items]
Stock split ratio, common stock	0.071
Common stock, shares authorized (in shares) | shares	107,142,857	107,142,857		1,000,000,000	107,142,857
Accumulated Deficit		$ 248,733			$ 222,758
Cash flows from operations		(21,951)	$ (71,555)
Cash and cash equivalents		15,165			$ 11,231
Aggregate gross proceeds		$ 30,000
Common Stock
Inventory [Line Items]
Reduction factor of authorized shares	1.5
Series A Convertible Preferred Stock
Inventory [Line Items]
Temporary equity, shares authorized (in shares) | shares	10,741,071	10,741,071		100,000,000	10,741,071
Reduction factor of authorized shares	1.5